Literature DB >> 34921008

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era.

Stefan M Pfister1,2,3, Miguel Reyes-Múgica4,5, John K C Chan6, Henrik Hasle7, Alexander J Lazar8, Sabrina Rossi9, Andrea Ferrari10, Jason A Jarzembowski11, Kathy Pritchard-Jones12, D Ashley Hill13, Thomas S Jacques14,15, Pieter Wesseling16,17, Dolores H López Terrada18, Andreas von Deimling19,20, Christian P Kratz21, Ian A Cree22, Rita Alaggio23.   

Abstract

Pediatric tumors are uncommon, yet are the leading cause of cancer-related death in childhood. Tumor types, molecular characteristics, and pathogenesis are unique, often originating from a single genetic driver event. The specific diagnostic challenges of childhood tumors led to the development of the first World Health Organization (WHO) Classification of Pediatric Tumors. The classification is rooted in a multilayered approach, incorporating morphology, IHC, and molecular characteristics. The volume is organized according to organ sites and provides a single, state-of-the-art compendium of pediatric tumor types. A special emphasis was placed on "blastomas," which variably recapitulate the morphologic maturation of organs from which they originate. SIGNIFICANCE: In this review, we briefly summarize the main features and updates of each chapter of the inaugural WHO Classification of Pediatric Tumors, including its rapid transition from a mostly microscopic into a molecularly driven classification systematically taking recent discoveries in pediatric tumor genomics into account. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34921008     DOI: 10.1158/2159-8290.CD-21-1094

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  4 in total

1.  Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.

Authors:  Andrey Korshunov; Konstantin Okonechnikov; Damian Stichel; Daniel Schrimpf; Alberto Delaidelli; Svenja Tonn; Martin Mynarek; Philipp Sievers; Felix Sahm; David T W Jones; Andreas von Deimling; Stefan M Pfister; Marcel Kool
Journal:  Acta Neuropathol       Date:  2022-06-30       Impact factor: 15.887

Review 2.  Immunovirotherapy for Pediatric Solid Tumors: A Promising Treatment That is Becoming a Reality.

Authors:  Daniel de la Nava; Kadir Mert Selvi; Marta M Alonso
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

3.  The systematic analysis and 10-year prediction on disease burden of childhood cancer in China.

Authors:  Bo Zhu; Xiaomei Wu; Wenxiu An; Bing Yao; Yefu Liu
Journal:  Front Public Health       Date:  2022-09-06

Review 4.  Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

Authors:  Andrea Ferrari; Bernadette Brennan; Michela Casanova; Nadege Corradini; Pablo Berlanga; Reineke A Schoot; Gema L Ramirez-Villar; Akmal Safwat; Gabriela Guillen Burrieza; Patrizia Dall'Igna; Rita Alaggio; Lisa Lyngsie Hjalgrim; Susanne Andrea Gatz; Daniel Orbach; Max M van Noesel
Journal:  Cancer Manag Res       Date:  2022-09-23       Impact factor: 3.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.